Skip to main content
Clinical Trials/ISRCTN22685192
ISRCTN22685192
Completed
Not Applicable

A double-blind, randomised controlled trial to assess the bioavilability of triterpenoids from pomace oil and their role on processes involved in the formation of the atheroclerotic plaque

Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovación [MICINN]) (Spain)0 sites12 target enrollmentJune 16, 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovación [MICINN]) (Spain)
Enrollment
12
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 16, 2011
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovación [MICINN]) (Spain)

Eligibility Criteria

Inclusion Criteria

  • Healthy males not suffering from hypertriglyceridemia

Exclusion Criteria

  • 1\. Age lower than 18 years and higher than 55 years
  • 2\. Hypertriglyceridemia
  • 3\. Hypertension
  • 4\. Coronary heart disease (CHD)
  • 5\. Renal or hepatic disease
  • 6\. Obesity
  • 7\. Diabetes
  • 8\. Alcoholism
  • 9\. Smoking
  • 10\. Under pharmacological treatment affecting lipid metabolism, coagulation or any condition of the study

Outcomes

Primary Outcomes

Not specified

Similar Trials